These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8819514)

  • 61. A brain on cannabinoids: the role of dopamine release in reward seeking.
    Oleson EB; Cheer JF
    Cold Spring Harb Perspect Med; 2012 Aug; 2(8):. PubMed ID: 22908200
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Altered Mesolimbic Dopamine System in THC Dependence.
    Spiga S; Lintas A; Diana M
    Curr Neuropharmacol; 2011 Mar; 9(1):200-4. PubMed ID: 21886590
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice.
    Kinsey SG; Naidu PS; Cravatt BF; Dudley DT; Lichtman AH
    Pharmacol Biochem Behav; 2011 Oct; 99(4):718-25. PubMed ID: 21740924
    [TBL] [Abstract][Full Text] [Related]  

  • 64. delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory.
    Wise LE; Varvel SA; Selley DE; Wiebelhaus JM; Long KA; Middleton LS; Sim-Selley LJ; Lichtman AH
    Psychopharmacology (Berl); 2011 Oct; 217(4):485-94. PubMed ID: 21559804
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug addiction.
    Justinova Z; Panlilio LV; Goldberg SR
    Curr Top Behav Neurosci; 2009; 1():309-46. PubMed ID: 21104390
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
    Stewart JL; McMahon LR
    J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats.
    Shram MJ; Siu EC; Li Z; Tyndale RF; Lê AD
    Psychopharmacology (Berl); 2008 Jun; 198(2):181-90. PubMed ID: 18385986
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
    Cooper ZD; Haney M
    Addict Biol; 2008 Jun; 13(2):188-95. PubMed ID: 18279497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats.
    Tallett AJ; Blundell JE; Rodgers RJ
    Psychopharmacology (Berl); 2007 Nov; 195(1):27-39. PubMed ID: 17639351
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MDMA attenuates THC withdrawal syndrome in mice.
    Touriño C; Maldonado R; Valverde O
    Psychopharmacology (Berl); 2007 Jul; 193(1):75-84. PubMed ID: 17387458
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.
    Guagnini F; Cogliati P; Mukenge S; Ferla G; Croci T
    Br J Pharmacol; 2006 Aug; 148(8):1165-73. PubMed ID: 16783406
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal delta9-tetrahydrocannabinol exposure.
    Suárez I; Bodega G; Fernández-Ruiz J; Ramos JA; Rubio M; Fernández B
    Cerebellum; 2004; 3(2):66-74. PubMed ID: 15233572
    [TBL] [Abstract][Full Text] [Related]  

  • 74. BAY 38-7271: a novel highly selective and highly potent cannabinoid receptor agonist for the treatment of traumatic brain injury.
    Mauler F; Horváth E; De Vry J; Jäger R; Schwarz T; Sandmann S; Weinz C; Heinig R; Böttcher M
    CNS Drug Rev; 2003; 9(4):343-58. PubMed ID: 14647528
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
    Tanda G; Goldberg SR
    Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.
    Vickers SP; Webster LJ; Wyatt A; Dourish CT; Kennett GA
    Psychopharmacology (Berl); 2003 Apr; 167(1):103-11. PubMed ID: 12632249
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cannabinoid addiction: behavioral models and neural correlates.
    Maldonado R; Rodríguez de Fonseca F
    J Neurosci; 2002 May; 22(9):3326-31. PubMed ID: 11978807
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.
    Aceto MD; Scates SM; Lowe JA; Martin BR
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1290-5. PubMed ID: 8819514
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.
    Aceto MD; Scates SM; Lowe JA; Martin BR
    Eur J Pharmacol; 1995 Aug; 282(1-3):R1-2. PubMed ID: 7498260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.